Cutaneous Melanoma Suspended Phase 2 Trials for Rasdegafusp alfa (DB15185)

IndicationStatusPhase
DBCOND0040978 (Cutaneous Melanoma)Suspended2
clinicaltrials.gov IdentifierTitlePurposeDrugs